Results 1 to 10 of about 4,692,840 (382)

Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy

Proceedings of the National Academy of Sciences of the United States of America, 1997
Although highly active antiretroviral therapy (HAART) in the form of triple combinations of drugs including protease inhibitors can reduce the plasma viral load of some HIV-1-infected individuals to undetectable levels, it is unclear what the effects of ...
Tae‐Wook Chun, Lieven Stuyver, Stephanie B. Mizell, Linda A. Ehler, Jo Ann M. Mican, Michael Baseler, Alun L. Lloyd, Martin A. Nowak, Anthony S. Fauci   +8 more
openalex   +2 more sources

Cause-Specific Mortality in HIV-Positive Patients Who Survived Ten Years after Starting Antiretroviral Therapy.

PLoS ONE, 2016
ObjectivesTo estimate mortality rates and prognostic factors in HIV-positive patients who started combination antiretroviral therapy between 1996-1999 and survived for more than ten years.MethodsWe used data from 18 European and North American HIV cohort
Adam Trickey, Margaret T May, Janne Vehreschild, Niels Obel, Michael John Gill, Heidi Crane, Christoph Boesecke, Hasina Samji, Sophie Grabar, Charles Cazanave, Matthias Cavassini, Leah Shepherd, Antonella d'Arminio Monforte, Colette Smit, Michael Saag, Fiona Lampe, Vicky Hernando, Marta Montero, Robert Zangerle, Amy C Justice, Timothy Sterling, Jose Miro, Suzanne Ingle, Jonathan A C Sterne, Antiretroviral Therapy Cohort Collaboration (ART-CC)   +24 more
doaj   +2 more sources

Multifocal Tuberculosis

Asian Journal of Medical Sciences, 2022
This is Letter to the ...
Ranjan Kumar Singh
doaj   +1 more source

Treatment Initiation, Program Attrition and Patient Treatment Outcomes associated with Scale-up and Decentralization of HIV care in rural Malawi [PDF]

, 2012
To describe patient antiretroviral therapy (cART) outcomes associated with intensive decentralization of services in a rural HIV program in ...
Annette Heinzelmann, Elisabeth Szumilin, Landon Myer, Loretxu Pinoges, Mar Pujades-Rodríguez, Martha Huckabee, Megan McGuire, Rupa Kanapathipillai, Simon Makombe, Tamika Munyenyembe   +9 more
core   +16 more sources

HIV and antiretroviral therapy-related fat alterations

Nature Reviews Disease Primers, 2020
Early in the HIV epidemic, lipodystrophy, characterized by subcutaneous fat loss (lipoatrophy), with or without central fat accumulation (lipohypertrophy), was recognized as a frequent condition among people living with HIV (PLWH) receiving combination ...
J. Koethe, C. Lagathu, J. Lake, P. Domingo, A. Calmy, J. Falutz, Todd T. Brown, J. Capeau   +7 more
semanticscholar   +1 more source

Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy

Annals of Internal Medicine, 2020
This study describes the incidence and severity of COVID-19 among 77 590 HIV-positive patients receiving antiretroviral therapy (ART). These findings warrant further investigation of HIV ART in HIV preexposure prophylaxis studies and randomized trials ...
Boghuma K. Titanji, Alfonso C. Hernandez-Romieu, Max W. Adelman   +2 more
semanticscholar   +1 more source

Mental health of people living with hiv and adherence to antiretroviral therapy

European Psychiatry, 2021
Introduction Adherence to antiretroviral therapy is a key factor in predicting the success or failure of treatment. Data suggest that the status of mental health and especially depression of people living with HIV can affect adherence to antiretroviral
F. Goma, G. Papazisis, E. Papakonstantinou, G. Karakioulakis   +3 more
doaj   +1 more source

HIV Associated Sensory Neuropathy [PDF]

Journal of Clinical and Diagnostic Research, 2014
Background: In the era of highly active antiretroviral therapy (HAART), sensory neuropathies have increased in prevalence. We have documented the frequency and profile of the two most common forms of sensory neuropathies associated with Human ...
Amruth G, Praveen-Kumar S, Nataraju B, Nagaraja BS   +3 more
doaj   +1 more source

Interleukin-2 therapy in patients with HIV infection [PDF]

, 2009
BACKGROUND Used in combination with antiretroviral therapy, subcutaneous recombinant interleukin-2 raises CD4+ cell counts more than does antiretroviral therapy alone. The clinical implication of these increases is not known.
Aagaard, B., Abrams, D., Angus, B., Aragon, E., Arnaiz, J., Babiker, A., Borup, L., Clotet, B., Collins, G., Cooper, D. A., Cordwell, B., Darbyshire, J., Dodds, W., Dragsted, U., Emery, S., Fau, A., Fleck, S., Fox, L., Gey, D., Gordin, F., Grarup, J., Grijsen, M., Hengge, U., Herrero, P., Jansson, P., Jensen, B., Jensen, K., Juncher, H., Lane, H. C., Lange, J., Langebeek, N., Lopez, P., Losso, M. H., Lundgren, J., Lundgren, J. D., Lévy, Y., Matthews, C., Mitsuyasu, R., Mollerup, D., Neaton, J. D., Pearson, M., Phillips, A., Reilev, S., Reiss, P., Routy, J. P., Tambussi, G., Tillmann, K., van der Horst, C., Varea, S., Wentworth, D.   +49 more
core   +5 more sources

Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection.

New England Journal of Medicine, 2015
BACKGROUND Data from randomized trials are lacking on the benefits and risks of initiating antiretroviral therapy in patients with asymptomatic human immunodeficiency virus (HIV) infection who have a CD4+ count of more than 350 cells per cubic millimeter.
J. Lundgren, A. Babiker, F. Gordin, S. Emery, B. Grund, Shweta Sharma, A. Avihingsanon, D. Cooper, G. Fätkenheuer, J. Llibre, J. Molina, P. Munderi, M. Schechter, R. Wood, K. Klingman, S. Collins, H. Lane, A. Phillips, J. Neaton   +18 more
semanticscholar   +1 more source